dc.contributor.author
Codes-Méndez, Helena
dc.contributor.author
Jeria-Navarro, Sicylle
dc.contributor.author
Park, Hye S
dc.contributor.author
Moya, Patricia
dc.contributor.author
Magallares López, Berta Paula
dc.contributor.author
Moltó, Elisabeth
dc.contributor.author
Álvaro, Yolanda
dc.contributor.author
Mariscal, Anaís
dc.contributor.author
Moga, Esther
dc.contributor.author
Tandaipan, Jose Luis
dc.contributor.author
Díaz Torne, César
dc.contributor.author
Laiz, Ana
dc.contributor.author
Sainz, Luis
dc.contributor.author
Castellvi, Ivan
dc.contributor.author
Corominas, Hèctor
dc.date.accessioned
2025-04-03T11:48:00Z
dc.date.available
2025-04-03T11:48:00Z
dc.identifier
https://ddd.uab.cat/record/305830
dc.identifier
urn:10.3390/jcm13206069
dc.identifier
urn:oai:ddd.uab.cat:305830
dc.identifier
urn:pmcid:PMC11508573
dc.identifier
urn:pmc-uid:11508573
dc.identifier
urn:pmid:39458019
dc.identifier
urn:oai:pubmedcentral.nih.gov:11508573
dc.identifier
urn:oai:egreta.uab.cat:publications/62ec8ff0-b8c5-44be-8a0c-e80ad23f3621
dc.identifier.uri
https://hdl.handle.net/2072/482608
dc.description.abstract
Objectives : Cryoglobulinemia (CG) is marked by abnormal immunoglobulins (Ig) in serum, precipitating at temperatures below 37 °C. Current classification categorizes CG into three subtypes (types I, II, and III) based on Ig clonality. The features distinguishing patients with CG based on their etiology remain unidentified. Aiming to characterize clinical and serological profiles of CG individuals, we conducted an observational analysis of a large cohort of patients and compared their characteristics based on underlying causes: hepatovirus (HV) infections, rheumatic diseases (RD), hematological disorders, and unidentified etiology (essential CG). Methods : We analyzed 252 cryoglobulin-positive serum samples from 182 patients and classified these into the four etiological groups. A separate sub-analysis was carried out for 10 patients meeting criteria for multiple diseases. We collected demographic, clinical, and laboratory data: CG characterization, complement (C3 and C4) levels, antinuclear antibodies (ANA), and rheumatoid factor (RF). Kruskal-Wallis and Wilcoxon-Mann-Whitney U- tests were used for comparisons. Results : Most patients (93.3%) had mixed cryoglobulinemia (types II + III), with 6.7% having type I. HV infection, predominantly hepatitis C, was the main (52.9%) associated condition within the cohort, followed by rheumatic (27.3%) and hematological (9.8%) disorders. In our cohort, ANA were frequent (45.3%) and often associated with RF positivity (43.6%) and decreased complement levels (C3: 42.4%, C4: 32.5%). Essential CG and CG associated with RD had a higher prevalence of cutaneous manifestations (p < 0.01) and renal involvement (p = 0.017). Hematological disorder-related CG showed higher cryoglobulin and RF concentrations (p < 0.01), despite milder symptoms. Conclusions : Our study underscores a mixed prevalence of CG across disease subgroups, with hepatitis-C virus as the primary factor, followed by rheumatic and hematological disorders. Four clinical and serological profiles of CG were identified based on their etiologies.
dc.format
application/pdf
dc.relation
Journal of clinical medicine ; Vol. 13, Núm. 20 (October 2024)
dc.rights
Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
dc.rights
https://creativecommons.org/licenses/by/4.0/
dc.subject
Cryoglobulinemia
dc.subject
Rheumatic disease
dc.subject
Hematological disease
dc.title
Clinical and Serological Profiles in Cryoglobulinemia : Analysis of Isotypes and Etiologies